Cannabis Sativa (CBDS) 10-K 14 Apr 22 2022 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2021	Apr. 04, 2022	Jun. 30, 2021
Cover [Abstract]
Entity Registrant Name	CANNABIS SATIVA, INC.
Entity Central Index Key	0001360442
Document Type	10-K
Amendment Flag	false
Entity Voluntary Filers	No
Current Fiscal Year End Date	--12-31
Entity Well Known Seasoned Issuer	No
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Current Reporting Status	Yes
Document Period End Date	Dec. 31, 2021
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Entity Ex Transition Period	false
Entity Common Stock Shares Outstanding		30,746,867
Entity Public Float			$ 10,803,000
Document Annual Report	true
Entity File Number	000-53571
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	20-1898270
Entity Interactive Data Current	Yes
Entity Address Address Line 1	450 Hillside Dr., #A224
Entity Address City Or Town	Mesquite
Entity Address State Or Province	NV
Entity Address Postal Zip Code	89024
Document Transition Report	false
Auditor Name	Assure CPA, LLC.
Auditor Location	Spokane, Washington
Auditor Firm Id	444
City Area Code	702
Local Phone Number	763-3123

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current Assets
Cash	$ 194,060	$ 322,107
Inventories	0	56,485
Investment in equity securities, at fair value	208,540	195,000
Other current assets	0	57,694
Total Current Assets	402,600	631,286
Other Assets
Property and equipment, net	1,974	199,120
Intangible assets, net	320,806	489,946
Deposits and other assets	0	9,250
Right to use asset	0	47,312
Goodwill	1,837,202	1,837,202
Total Assets	2,562,582	3,214,116
Current Liabilities
Accounts payable and accrued expenses	95,031	179,200
Accrued interest - related parties	204,613	144,024
Advances from related parties	0	18,800
Notes payable to related parties	1,218,038	1,161,020
Customer deposits	0	25,545
Operating lease liability - current	0	31,891
Total Current Liabilities	1,517,682	1,560,480
Long-Term Liabilities
Operating lease liability - long term	0	15,421
Total Liabilities	1,517,682	1,575,901
Stockholders' Equity (Deficit):
Preferred stock $0.001 par value; 5,000,000 shares authorized; 777,654 and 1,090,128 issued and outstanding, respectively	778	1,090
Common stock $0.001 par value; 45,000,000 shares authorized; 30,746,865 and 27,453,178 shares issued and outstanding, respectively	30,748	27,455
Additional paid-in capital	79,151,240	77,660,014
Accumulated deficit	(79,475,968)	(77,028,339)
Total Cannabis Sativa, Inc. Stockholders' Equity (Deficit)	(293,202)	660,220
Non-Controlling Interests	1,338,102	977,995
Total Stockholders' Equity	1,044,900	1,638,215
Total Liabilities and Stockholders' Equity	$ 2,562,582	$ 3,214,116

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2021	Dec. 31, 2020
CONSOLIDATED BALANCE SHEETS
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	777,654	1,090,128
Preferred Stock, Shares Outstanding	777,654	1,090,128
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	45,000,000	45,000,000
Common Stock, Shares, Issued	30,746,865	27,453,178
Common Stock, Shares, Outstanding	30,746,865	27,453,178

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
CONSOLIDATED STATEMENTS OF OPERATIONS
Revenues	$ 1,841,558	$ 1,940,731
Cost of Revenues	699,378	740,645
Gross Profit	1,142,180	1,200,086
Operating Expenses
Professional fees	581,660	750,030
Depreciation and amortization	171,163	207,866
Wages and salaries	711,872	596,262
Advertising	344,904	467,918
General and administrative	1,078,204	971,598
Total Operating Expenses	2,887,803	2,993,674
Loss from Operations	(1,745,623)	(1,793,588)
Other Income (Expenses)
Gain (loss) on investment in equity securities	(542,442)	147,000
Gain on forgiveness of CAREs Act Loan	5,000	0
Interest expense - related parties	(66,872)	(60,356)
Total Other Income (Expenses), Net	(604,314)	86,644
Net Loss Before Income Taxes	(2,349,937)	(1,706,944)
Income Taxes	0	0
Net Loss from Continuing Operations	(2,349,937)	(1,706,944)
Net Income (Loss) from Discontinued Operations
Operating loss on discontinued operations	(234,205)	(751,600)
Gain on sale of subsidiaries	164,736	0
Net Income (Loss) from Discontinued Operations	(69,469)	(751,600)
Net Loss	(2,419,406)	(2,458,544)
Loss attributable to non-controlling interest - GK Manufacturing	(114,467)	(367,792)
Loss attributable to non-controlling interest - iBudTender	(1,614)	(3,878)
Income attributable to non-controlling interest - PrestoCorp	144,304	86,318
Net Loss Attributable To Cannabis Sativa, Inc.	$ (2,447,629)	$ (2,173,192)
Net Loss per Common Share: Basic and diluted
From continuing operations	$ (0.08)	$ (0.06)
From discontinued operations	0	(0.03)
Total	$ (0.08)	$ (0.09)
Weighted Average Common Shares Outstanding:
Basic & Diluted	29,283,393	25,408,676

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY - USD ($)	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Non Controlling Interest Prestocorp	Non Controlling Interest iBud Tender	Non Controlling Interest GK Manufacturing
Balance, shares at Jan. 01, 2020		1,021,849	22,224,199
Balance, amount at Jan. 01, 2020	$ 1,160,754	$ 1,021	$ 22,226	$ 74,834,032	$ (74,855,147)	$ 1,107,480	$ 51,142	$ 0
Conversion of Preferred to Common, shares		(503,681)	503,681
Conversion of Preferred to Common, amount	0	$ (504)	$ 504	0	0	0	0	0
Acquisition of GK Manufacturing, shares			100,000
Acquisition of GK Manufacturing, amount	213,725	0	$ 100	108,900	0	0	0	104,725
Cash proceeds from sale of stock and warrants, shares			50,000
Cash proceeds from sale of stock and warrants, amount	25,000	$ 0	$ 50	24,950	0	0	0	0
Shares issued for services, shares		348,746	3,612,060
Shares issued for services, amount	2,056,595	$ 350	$ 3,612	2,052,633	0	0	0	0
Shares issued for stock payable, shares		223,214	963,238
Shares issued for stock payable, amount	640,685	$ 223	$ 963	639,499	0	0	0	0
Net income (loss) for the year	(2,458,544)	$ 0	$ 0	0	(2,173,192)	86,318	(3,878)	(367,792)
Balance, shares at Dec. 31, 2020		1,090,128	27,453,178
Balance, amount at Dec. 31, 2020	1,638,215	$ 1,090	$ 27,455	77,660,014	(77,028,339)	1,193,798	47,264	(263,067)
Net income (loss) for the year	(2,419,406)
Balance, shares at Dec. 31, 2021		777,654	30,746,865
Balance, amount at Dec. 31, 2021	1,044,900	$ 778	$ 30,748	79,151,240	(79,475,968)	1,338,102	0	0
Balance, shares at Jan. 01, 2021		1,090,128	27,453,178
Balance, amount at Jan. 01, 2021	1,638,215	$ 1,090	$ 27,455	77,660,014	(77,028,339)	1,193,798	47,264	(263,067)
Conversion of Preferred to Common, shares		(622,645)	622,645
Conversion of Preferred to Common, amount	0	$ (622)	$ 622	0	0	0	0	0
Cash proceeds from sale of stock and warrants, shares			10,466
Cash proceeds from sale of stock and warrants, amount	5,000	$ 0	$ 11	4,989	0	0	0	0
Shares issued for services, shares		310,171	2,716,132
Shares issued for services, amount	1,509,207	$ 310	$ 2,716	1,506,181	0	0	0	0
Net income (loss) for the year	(2,419,406)	0	$ 0	0	(2,447,629)	144,304	(1,614)	(114,467)
Cancellation of shares issued for services, shares			(55,556)
Cancellation of shares issued for services, amount	(20,000)	0	$ (56)	(19,944)	0	0	0	0
Sale of non-controlling interests	331,884	$ 0	$ 0	0	0	0	(45,650)	377,534
Balance, shares at Dec. 31, 2021		777,654	30,746,865
Balance, amount at Dec. 31, 2021	$ 1,044,900	$ 778	$ 30,748	$ 79,151,240	$ (79,475,968)	$ 1,338,102	$ 0	$ 0

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,419,406)	$ (2,458,544)
Adjustments to reconcile net loss to net cash provided (used) by operating activities:
(Gain) loss on investment in equity securities	542,442	(147,000)
Gain on sale of subsidiaries	(164,736)	0
Depreciation and amortization	188,114	235,624
Gain on forgiveness of CARES Act Loan	(5,000)	0
Shares issued for services	1,489,207	2,056,595
Note payable issued for services	25,000	0
Changes in Assets and Liabilities:
Inventories	27,499	(8,498)
Other current assets	(11,380)	(49,144)
Deposits and other assets	0	8,000
Accounts payable and accrued expenses	20,344	105,621
Accrued interest - related parties	60,589	56,045
Customer deposits	1,341	25,545
Net Cash Used in Operating Activities	$ (245,986)	$ (191,756)
Cash Flows from Investing Activities:
Cash transferred on sale of subsidiaries	(21,321)	0
Proceeds from sale of equity securities	$ 44,017	$ 0
Purchase of property and equipment	0	(58,544)
Advance to GK settled with asset acquisition	0	50,000
Net Cash Provided by (Used in) Investing Activities	22,696	(8,544)
Cash Flows from Financing Activities:
Proceeds from sale of common stock and warrants	5,000	25,000
Proceeds from advances from related parties, net	48,083	18,800
Proceeds from related parties notes payable	42,160	142,500
Net Cash Provided by Financing Activities	95,243	186,300
NET CHANGE IN CASH	(128,047)	(14,000)
CASH AT BEGINNING OF YEAR	322,107	336,107
CASH AT END OF YEAR	194,060	322,107
Noncash investing and financing activities:
Net asset acquisition acquired with shares of common stock	0	213,725
Common stock issued from stock payable	0	640,685
Operating lease liability from acquiring right to use asset	0	61,367
Advances from related parties exchanged for notes payable related parties	0	1,008,378
Investment in equity securities received in exchange for sale of controlling interest in subsidiaries controlling interest in subsidiaries	$ 600,000	$ 0

Organization and Summary of Sig

Organization and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Organization and Summary of Significant Accounting Policies
1. Organization and Summary of Significant Accounting Policies	1. Organization and Summary of Significant Accounting Policies Nature of Business: Cannabis Sativa, Inc. (the “Company,” “us”, “we” or “our”) was incorporated as Ultra Sun Corp. under the laws of Nevada in November 2004. On November 13, 2013, we changed our name to Cannabis Sativa, Inc. We operate through several subsidiaries including: · PrestoCorp, Inc. (“PrestoCorp”) · iBudtender, Inc. (“iBud”) – through April 2021 · Wild Earth Naturals, Inc. (“Wild Earth”) · Kubby Patent and Licenses Limited Liability Company (“KPAL”) · Hi Brands, International, Inc. (“Hi Brands”) · GK Manufacturing and Packaging, Inc. (“GKMP”)- through April 2021 · Eden Holdings LLC (“Eden”). PrestoCorp is a 51% owned subsidiary and until April 22, 2021, GKMP and iBud were 51% and 50.1% owned subsidiaries. Wild Earth, KPAL, Hi Brands, and Eden are wholly owned subsidiaries. At December 31, 2021, PrestoCorp is the sole operating subsidiary. Until sale of the Company’s interest in April 2021, GKMP and iBud tender were operating subsidiaries although iBud was not generating any revenue. Our primary operations for the years ended December 31, 2021 and 2020 were through PrestoCorp, which provides telemedicine online referral services for customers desiring medical marijuana cards in states where medical marijuana has been legalized. The Company is actively seeking new business opportunities for acquisition and is continually reviewing opportunities for product and brand development through our Wild Earth, Hi Brands, and KPAL subsidiaries. Principles of Consolidation: The consolidated financial statements include the accounts of Cannabis Sativa, Inc. (the “Company” or “CBDS”), and its wholly-owned subsidiaries and PrestoCorp, a 51% owned subsidiary. On April 22, 2021, we sold our interests in two companies in which the Company had majority control, iBud and GKMP. These consolidated financial statements include operations of iBud and GKMP through April 22, 2021. All significant inter-company balances have been eliminated in consolidation. Non-controlling Interests: Non-controlling interests are portions of entities included in the condensed consolidated financial statements that are not attributable to the Company. Non-controlling interest are identified separately from the Company’s stockholders’ equity and its net income (loss). Non-controlling interest equity balances include the non-controlling entity’s initial contribution at the date of the original acquisition, ongoing contributions, distributions, and percentage share of earnings since inception. The non-controlling interests are calculated based on percentages of ownership. Going Concern: The Company has an accumulated deficit of $79,475,968 and negative working capital of $1,115,082 at December 31, 2021, which, among other factors, raises substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to generate profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they are due. Use of Estimates: Inventories: As of December 31, 2021 and 2020, the Company had $-0- and $56,485, respectively, in inventory relating to GKMP which consisted of the raw materials and packaging used to manufacture cannabidiol (“CBD”) infused products for our customers. Property and Equipment: Property and equipment are recorded at cost. Depreciation is provided for on the straight-line method over the estimated useful lives of the assets. The average lives range from five (5) to ten (10) years. Leasehold improvements are amortized on the straight-line method over the lesser of the lease term or the useful life. When assets are retired or sold, the costs and related accumulated depreciation are eliminated from the accounts and any resulting gain or loss is reflected in operations. Maintenance and repairs that neither materially add to the value of the property nor appreciably prolong its life are charged to expense as incurred. Betterments or renewals are capitalized when incurred. Fair Value of Financial Instruments: Cash: Cash is held at major financial institutions and insured by the Federal Deposit Insurance Corporation (FDIC) up to federal insurance limits. The Company considers all highly liquid investments purchased with an original maturity of three months or less when acquired to be cash equivalents. Net Loss per Share: Investments: Equity securities of investments in which the Company owns less than 20% and/or has no significant influence are generally measured at fair value with changes in fair value recognized in earnings. Upon sale of an equity security, the realized gain or loss is recognized in earnings. Investments in companies in which the Company owns more than 20% and has the ability to exercise significant influence, but do not control, are accounted for under the equity method of accounting. In determining whether significant influence exists, the Company will consider its participation in policy-making decisions and representation on governing bodies. Under the equity method of accounting, the Company’s share of the net earnings or losses of the investee are included in earnings. The Company may elect to account for certain equity method investments at fair value whereby the carrying value of the investment is adjusted to fair value at the end of each period and the related change in fair value is recognized in earning. For these investments, the Company’s share of the net earnings or losses of the investee are not included in earnings. Companies in which the Company holds investments amounting to more than 50% of the voting interests, but less than 100%, and in which the Company has significant influence, are consolidated and other investor interests are presented as non-controlling. Revenue Recognition: In the years ending December 31, 2021 and 2020, the Company operated two divisions, the telehealth business operated through PrestoCorp and the contract manufacturing business operated through GKMP. The contract manufacturing business was sold on April 22, 2021, and the Company now operates only the telehealth division. The telehealth division generates revenue based on a per telehealth visit for clients looking to obtain a permit to use marijuana for medical purposes in states that have legalized medical marijuana. Revenues are recognized when the Company satisfies its performance obligation to provide telehealth services upon a referral to a contracted physician. The obligation to perform the referral and the referral are automated and occur at the same time an online client subscribes for the visit and gains access to our network of health care professionals. Recognition of revenue is not dependent on the issuance of a marijuana card since issuance of the card is dependent on health and other factors beyond our control. This initial service is a one-time referral to a physician. Clients may return for other telehealth consultations, typically regarding product recommendations, and such additional physician referrals are provided at an additional cost. The billing and payment processes for each physician referral are automated through our online platform. Revenue is recognized in an amount that reflects the consideration that is received in exchange for each physician referral provided to the client. The contract manufacturing division recognized revenue from manufacturing operations when the products are shipped to the customer. In some instances, customers provided inventory for the manufacturing process and GKMP provided labor, supplies and manufacturing operations to mix and package the products. Revenues were recognized when the manufacturing and packaging process were completed, and the goods were shipped to the customer. In other instances, the Company acquired inventory and manufactured products for customers and/or to be held in inventory for later sale to customers through the GKMP on-site dispensary, through the GKMP online store, or to independent distributors. In these instances, revenue was recognized when the product was shipped to the customer or distributor. Shipment terms were FOB origination. The Company sold its interest in GKMP during 2021 and no longer recognizes revenue from the contract manufacturing division. Provision for sales incentives, discounts and returns and allowances, if applicable, are accounted for as reductions of revenue in the period the related sales are recorded. The Company had no warranty costs associated with the sales of its products. Intangible Assets and Goodwill: Intangible asset amounts represent the acquisition date fair values of identifiable intangible assets acquired. The fair values of the intangible assets were determined by using the income approach, discounting projected future cash flows based on management’s expectations of the current and future operating environment. The rates used to discount projected future cash flows reflected a weighted average cost of capital based on our industry, capital structure and risk premiums including those reflected in the current market capitalization. Definite-lived intangible assets are amortized over their useful lives, which have historically ranged from 5 to 10 years. The carrying amounts of our definite-lived intangible assets are evaluated for recoverability whenever events or changes in circumstances indicate that the entity may be unable to recover the asset’s carrying amount. We do not have any indefinite-lived intangible assets recorded from acquisitions. Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill is not amortized but is tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset may be impaired. The fair value of the reporting unit is evaluated on qualitative factors to determine if the reported value may be impaired. If the qualitative factors indicate a likelihood of impairment, we then evaluate carrying value of the reporting unit based on quantitative factors using the income approach. An impairment charge is recognized for the excess of the carrying value of goodwill for the reporting unit over its implied fair value. Advertising Expense: Advertising costs are expensed as incurred and are broken out separately in the accompanying consolidated statements of operations. Stock-Based Compensation: Stock-based payments to employees and non-employees are recognized at their fair values. Compensation expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). Transactions in which goods or services are received for the issuance of shares of the Company’s preferred or common stock are accounted for based on the fair value of the common stock issued. The Company currently recognizes compensation costs immediately as our awards are 100% vested at the time of issuance. Forfeitures are recognized upon occurrence. Income Taxes: The Company utilizes the liability method of accounting for income taxes which requires that deferred tax assets and liabilities be recorded to reflect the future tax consequences of temporary differences between the book and tax basis of various assets and liabilities. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Additionally, deferred tax assets are evaluated, and a valuation allowance is established if it is more likely than not that all or a portion of the deferred tax asset will not be realized. There can be no assurance that the Company’s future operations will produce sufficient earnings so that the deferred tax asset can be fully utilized. The Company currently maintains a full valuation allowance against net deferred tax assets. Uncertain tax positions are evaluated in a two-step process, whereby (i) it is determined whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (ii) for those tax positions that meet the more-likely-than-not recognition threshold, the largest amount of tax benefit that is greater than 50% likely of being realized upon ultimate settlement with the related tax authority would be recognized. Leases: The Company determines if an arrangement is a lease, or contains a lease, at the inception of an arrangement. If the Company determines that the arrangement is a lease, or contains a lease, at lease inception, it then determines whether the lease is an operating lease or finance lease. Operating and finance leases result in recording a right-to-use (“RTU”) asset and lease liability on the consolidated balance sheets. RTU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease RTU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. For purposes of calculating operating lease RTU assets and operating lease liabilities, the Company uses the non-cancellable lease term plus options to extend that it is reasonably certain to exercise. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. The Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company has elected not to recognize RTU assets and lease liabilities that arise from short-term (12 months or less) leases for any class of underlying asset. The Company has elected not to separate lease and non-lease components for any class of underlying asset. Fair Value Measurements: When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. We measure our investment in equity securities at fair value on a recurring basis. The Company’s equity securities are valued using inputs observable in active markets and are therefore classified as Level 1 within the fair value hierarchy. Contingencies: In determining accruals and disclosures with respect to loss contingencies, the Company evaluates such accruals and contingencies for each reporting period. Estimated losses from loss contingencies are accrued by a charge to income when information available prior to issuance of the financial statements indicates that it is probable that a liability could be incurred, and the amount of the loss can be reasonably estimated. Legal expenses associated with the contingency are expensed as incurred. If a loss contingency is not probable or reasonably estimable, disclosure of the loss contingency is made in the financial statements when it is at least reasonably possible that a material loss could be incurred. Recent Accounting Pronouncement: Accounting Standards Updates Adopted In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The update contains a number of provisions intended to simplify the accounting for income taxes. Adoption of this update on January 1, 2021 had no impact on the Company’s consolidated financial statements. Accounting Standards Updates to Become Effective in Future Periods In August 2020, the FASB issued ASU No. 2019-12 Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The update is to address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity. The update is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years and with early adoption permitted. Management is evaluating the impact of this update on the Company’s consolidated financial statements. Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2021
Property and Equipment
2. Property and Equipment	2. Property and Equipment Property and equipment consisted of the following at December 31, 2021 and 2020: 2021 2020 Furniture and Equipment $ 15,052 $ 225,629 Leasehold Improvements 2,500 17,315 Total Property and Equipment 17,552 242,944 Less: Accumulated Depreciation (15,578 ) (43,824 ) Net Property and Equipment $ 1,974 $ 199,120 Depreciation expense for the years ended December 31, 2021 and 2020 was $18,972 and $30,352, respectively.

Intangibles and Goodwill

Intangibles and Goodwill	12 Months Ended
	Dec. 31, 2021
Intangibles and Goodwill
3. Intangibles and Goodwill	3. Intangibles and Goodwill The Company considers all intangibles to be definite-lived assets with lives of 5 to 10 years. Intangibles consisted of the following at December 31, 2021 and 2020: 2021 2020 CBDS.com website (Cannabis Sativa) $ 13,999 $ 13,999 Intellectual Property Rights (PrestoCorp) 240,000 240,000 Patents and Trademarks (KPAL) 1,281,411 1,281,411 Total Intangibles 1,535,410 1,535,410 Less: Accumulated Amortization (1,214,604 ) (1,045,464 ) Net Intangible Assets $ 320,806 $ 489,946 Amortization expense for the years ended December 31, 2021 and 2020 was $169,140, and $205,272, respectively. Amortization of intangibles through 2026 is: 2022 $ 161,865 2023 151,686 2024 3,051 2025 932 2026 932 Goodwill in the amount of $3,010,202 was recorded as part of the acquisition of PrestoCorp that occurred on August 1, 2017. Cumulative impairment of the PrestoCorp goodwill totals $1,173,000 as of December 31, 2021 and 2020. The balance of goodwill at December 31, 2021 and 2020 was $1,837,202. There were no additions, deletions, and impairments recognized in the years ended December 31, 2021 and 2020. The Company considered the impact of COVID-19 on intangible assets at December 31, 2021 and 2020 and concluded that impairment analysis is not necessary.

Sale of Majority Owned Subsidia

Sale of Majority Owned Subsidiaries and Discontinued Operations	12 Months Ended
	Dec. 31, 2021
Sale of Majority Owned Subsidiaries and Discontinued Operations
4. Sale of Majority Owned Subsidiaries and Discontinued Operations	4. Sale of Majority Owned Subsidiaries and Discontinued Operations On April 22, 2021, the Company sold its majority interests in GKMP (51%) and iBud (50.1%) to THC Farmaceuticals, Inc. (“CBDG”). In consideration of the transaction, the Company received 1,500,000 shares of CBDG common stock and 1,500,000 shares of CBDG preferred stock. The Company’s Chief Executive Officer and Chairman of the Board, David Tobias is a Director of CBDG. Shares of CBDG common stock are traded on the OTC Pink Sheets Market. The sale of the Company’s majority interests was undertaken to allow the Company to focus on its other operating subsidiary, PrestoCorp, to focus on capital formation for expansion of PrestoCorp, and to pursue other opportunities. At the time of the sale, iBud was inactive and GKMP had not yet achieved positive cash flow from operations. On the closing date of the sale, CBDG common shares closed at $0.20 per share, for a fair value of $300,000. The CBDG preferred stock received is convertible into CBDG common stock on a one for one basis and has no other rights or preferences that distinguish it from the common stock and are convertible at any time by the Company. Management determined that the shares of preferred stock received are equivalent to CBDG’s common stock and valued the preferred shares at the same rate. In the aggregate, the total shares of CBDG stock received were valued at $600,000 on the date of the sale. The Company recognized a gain on sale of subsidiaries of $164,736 which represented the value of the consideration received consisting of the value of CBDG’s shares plus the carrying value of the subsidiaries’ non-controlling interest reduced by the net asset of each subsidiary: Consideration received: Common stock of CBDG, fair value $ 300,000 Preferred stock of CBDG, fair value 300,000 Total consideration 600,000 Non-controlling interests (331,884 ) Net assets of subsidiaries on date of disposition: GKMP 112,350 iBud (8,970 ) Net assets 103,380 Gain on sale of subsidiaries $ 164,736 As a result of the sale, the Company has discontinued its operations for both subsidiaries. Summaries of the discontinued operations of GKMP and iBud for the period January 1, 2021 to April 22, 2021 (date of disposition) and the year ended December 31, 2020 are provided below. Period Year Ended Ended DISCONTINUED OPERATIONS OF GKMP January 1 to April 22, 2021 December 31, 2020 REVENUE $ 75,866 $ 94,552 Cost of revenues 91,316 152,837 Gross profit (15,450 ) (58,285 ) OPERATING EXPENSES Depreciation and amortization 5,526 8,898 Wages and salaries 106,224 213,765 Advertising 1,693 36,056 General and administrative 104,177 433,592 Total operating expenses 217,620 692,311 NET LOSS FROM OPERATIONS (233,070 ) (750,596 ) DISCONTINUED OPERATIONS OF IBUD REVENUE $ - $ - OPERATING EXPENSES Depreciation and amortization 1,135 1,004 Total operating expenses 1,135 1,004 NET LOSS FROM OPERATIONS (1,135 ) (1,004 ) Aggregate net loss from discontinued operations (234,205 ) (751,600 ) Gain on sale of discontinued operations 164,736 - NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS (69,469 ) (751,600 ) GKMP and iBud generated losses from operations during the periods they were operated by the Company. The sale of our interests in GKMP and iBud will now allow management to devote more resources to PrestoCorp.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2021
Related Party Transactions
5. Related Party Transactions	5. Related Party Transactions In addition to items disclosed in Notes 4 and 7, the Company had additional related party transactions during 2021 and 2020. The Company has received funds from borrowings on notes payable and advances from related parties and officers of the Company to cover operating expenses. Related parties include the officers and directors of the Company and a significant shareholder holding in excess of 10% of the Company’s outstanding shares. In 2020, the Company converted all of the outstanding advances into one-year notes due on December 31, 2020 bearing interest at 5%. New borrowings on notes payable in the year ended December 31, 2020 were $142,500. In April 2021, the notes were extended to December 31, 2021. The Company is currently in discussions with the note holders to covert these notes into long-term obligations, but the terms have not been finalized. During the year ended December 31, 2021, David Tobias loaned $42,160 to the Company for notes payable bearing interest at the rate of 5% per annum due on December 31, 2021. In the year ended December 31, 2021, the Company and Cathy Carroll, director, entered into a note payable for $25,000 for compensation due her for services. Ms. Carroll’s note bears interest at 5% per annum and is due December 31, 2021. The notes payable to Mr. Tobias and Ms. Carroll were extended and are now due December 31, 2022. During the years ended December 31, 2021 and 2020, the Company recorded interest expense related to these notes payable at the rates between 5% and 8% per annum in the amounts of $66,872 and $60,356, respectively. In 2021, the Company received short-term advances from the principals of GKMP in the amounts of $48,083 bringing the balance due to $67,058. These advances are not interest bearing. The advances were assumed by the acquirer of GKMP and are no longer an obligation of the Company. See Note 4. At December 31, 2020, the Company had a note payable to the founder of iBud of $10,142. This note was assumed by the acquirer of IBud and is no longer an obligation of the Company. See Note 4. The following tables reflect the related party advance and note payable balances. Notes payable to related parties Accrued interest -related parties December 31, 2021 David Tobias, CEO & Director $ 986,538 $ 169,057 New Compendium, greater than 10% Shareholder 152,500 27,688 Cathy Carroll, Director 75,000 7,068 Other Affiliates 4,000 800 Totals $ 1,218,038 $ 204,613 Advances from related parties Notes payable to related parties Accrued interest -related parties December 31, 2020 David Tobias, CEO & Director $ — $ 944,378 $ 120,293 New Compendium, Affiliate — 152,500 20,063 Keith Hyatt, Affiliate (GKMP) 13,100 — — Jason Washington, Affiliate (GKMP) 5,700 — — Chris Cope, Affiliate (iBudtender) — 10,142 — Cathy Carroll, Director — 50,000 3,068 Other Affiliates — 4,000 600 Totals $ 18,800 $ 1,161,020 $ 144,024 In the years ended December 31, 2021 and 2020, the Company incurred approximately $111,100 and $162,300, respectively, for consulting services from a nephew of the Company’s president. These services were paid in shares of the Company’s common stock. These amounts are included in the statements of operations in general and administrative expenses.

Investments

Investments	12 Months Ended
	Dec. 31, 2021
Investments
6. Investments	6. Investments At December 31, 2021 and 2020, the Company owns 8,238,769 shares and 10,000,000 shares, respectively, of common stock of Medical Cannabis Payment Solutions (ticker: REFG). At December 31, 2021 and 2020, the fair value of the investment in REFG is $25,540 and $195,000, respectively. The Company recognized a gain (loss) on the change in fair value of ($134,235) and $147,000 during the years ended December 31, 2021 and 2020, respectively. During the year ended December 31, 2021, the Company sold 1,761,231 shares for proceeds of $44,017 and realized a gain of $8,793. No shares of REFG were sold in 2020. In 2021, the Company received 1,500,000 shares of common stock and 1,500,000 shares of preferred stock of THC Pharmaceuticals Inc. (ticker: CBDG). The CBDG shares were received as consideration for the sale of the Company’s majority interest in iBud and GKMP in the year ended December 31, 2021. On the date of sale, the shares were valued at fair value which was $0.20 per share or $600,000 in the aggregate. See Note 4. The Company’s Chief Executive Officer and Chairman of the Board, David Tobias is a Director of CBDG. The Company’s investment in CBDG represents 15% of CBDG’s voting shares on a fully diluted basis which, coupled with Mr. Tobias’ position as a director and his individual investment in CBDG, results in the Company having significant influence over CBDG. The Company elected to account for its investment in CBDG at fair value because the Company does not intend to hold the investment for a long period of time and the shares are readily marketable. The fair value of the Company’s investment at December 31, 2021 was $183,000 resulting in a loss of $417,000 for the change in fair value during the year ended December 31, 2021.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2021
Stockholders' Equity
7. Stockholders' Equity	7. Stockholders’ Equity Securities Issuances Share Issuances Services Common Preferred Value Related Party issuances David Tobias, Officer, Director - 310,171 $ 150,000 Brad Herr, Officer, Director 516,949 - 250,000 Robert Tankson, Director 61,236 - 29,961 Cathy Carroll, Director 203,027 - 112,500 Trevor Reed, Director 51,696 - 25,000 Total related party issuances 832,908 310,171 $ 567,461 Non-related party issuances 1,883,224 - $ 941,746 Total shares for services 2,716,132 310,171 $ 1,509,207 Issuance for cash 10,466 5,000 Preferred stock converted to common 622,645 (622,645 ) - Shares cancelled (55,556 ) - $ (20,000 ) Aggregate totals 3,293,687 (312,474 ) $ 1,494,207 During the year ended December 31, 2021, the Company cancelled shares that had been returned after it was determined the shares have been erroneously issued to a vendor in 2020. Share Issuances Shares issued for stock payable Common Preferred Value Related party issuance 521,411 223,214 $ 431,201 Non-related party issuance 441,827 - 209,484 Total shares for stock payable 963,238 223,214 $ 640,685 Conversion of preferred stock 503,681 (503,681 ) $ - Services Related party issuances David Tobias, Officer, Director - 348,746 $ 175,964 Brad Herr, Officer, Director 498,878 - 250,201 Robert Tankson, Director 127,570 - 62,661 Cathy Carroll, Director 348,746 - 175,964 Trevor Reed, Director 58,125 - 29,328 Keith Hyatt, President GKMP 278,237 - 140,237 Kyle Powers, CEO PrestoCorp 92,593 - 44,444 Total related party issuances 1,404,149 348,746 878,799 Non-related Party issuances 2,207,911 - 1,177,794 Total shares for services 3,612,060 348,746 $ 2,056,593 Issuance for Cash 50,000 - $ 25,000 Issuance for acquisitions 100,000 - $ 109,000 Aggregate totals 5,228,979 68,279 $ 2,831,278 During the years ended December 31, 2021 and 2020, David Tobias, Chief Executive Officer and Director, converted 622,645 and 503,681 shares of preferred stock into an equal number of common stock in accordance with the terms of the preferred stock, respectively. In the year ended December 31, 2020, the Company acquired a 51% interest in GKMP. The consideration for the acquisition was 100,000 shares of common stock valued at $109,000 on the date of the acquisition. The Company subsequently divested its interest in GKMP. See Note 4. Stock Compensation Plans 2017 Stock Plan On July 28, 2017, the Company adopted the Cannabis Sativa 2017 Stock Plan which authorized the Company to utilize common stock to compensate employees, officers, directors, and independent contractors for services provided to the Company. The Company authorized up to 3,000,000 shares of common stock to be issued pursuant to the 2017 Stock Plan. At December 31, 2021, no shares were available for further issuance under this plan. 2020 Stock Plan On September 25, 2020, the Company adopted the Cannabis Sativa 2020 Stock Plan which authorized the Company to utilize common stock to compensate employees, officers, directors, and independent contractors for services provided to the Company. By resolution dated September 25, 2020, the Company authorized up to 1,000,000 shares of common stock to be issued pursuant to the 2020 Stock Plan. This amount was subsequently increased to 2,000,000 shares on January 27, 2021. At December 31, 2021, 1,350,667 shares were available for future issuance. Warrants During the year ended December 31, 2020, 50,000 warrants were issued by the Company and 49,900 warrants expired. No warrants were issued or exercised in 2021 and no warrants were exercised during either year. At December 31, 2021, warrants expire as follows: Shares Exercise Price Expiration Date 125,000 $ 0.80 November 2022 50,000 $ 2.00 July and August 2023 175,000

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies
8. Commitments and Contingencies	8. Commitments and Contingencies Leases. PrestoCorp leases office space through WeWork in New York for $2,444 per month on a month-to-month arrangement. Rent expense for the years ended December 31, 2021 and 2020 was $36,922 and $38,458, respectively. GKMP leased a facility in Anaheim California where its operations are based. The Anaheim lease included approximately 16,000 square feet of combined office, manufacturing, and warehouse space. Rent expense for the years ended December 31, 2021 and 2020 was $77,119 and $139,398, respectively. GKMP also leased a commercial printer and a bottle filling line, both of which are used in its manufacturing and packaging operations. For the years ended December 31, 2021 and 2020, the Company recognized $7,555 and $22,527, respectively, in lease expense on these two items. Lease expense is reported as cost of goods sold in the consolidated statements of operations. On April 22, 2021, the Company sold its majority interest in GKMP and these lease obligations were assumed by the acquirer of GKMP and are no longer an obligation of the Company. See Note 4. Litigation. Shares in Escrow.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2021
Income Taxes
9. Income Taxes	9. Income Taxes The Company did not recognize a tax provision or benefit for the years ended December 31, 2021 and 2020 due to ongoing net losses and a valuation allowance. At December 31, 2021 and 2020, the Company had net deferred tax assets which will not be realized and are fully reserved by valuation allowances. At December 31, 2021 and 2020, the Company had net deferred tax assets principally arising from net operating loss carryforward for income tax purposes and differences in the carrying values of goodwill and intangibles between the Company’s financial statements and its income tax returns. As management of the Company cannot determine that it is more likely than not that the Company will realize the benefit of the deferred tax assets, a valuation allowance equal to 100% of the net deferred tax asset exists at December 31, 2021 and 2020. The components of the Company’s net deferred tax assets at December 31, 2021 and 2020 are as follows: 2021 2020 Deferred tax asset: Net operating loss carryforwards $ 3,812,000 $ 3,424,000 Intangibles and goodwill 1,034,000 998,000 Investments 82,000 5,000 Other 45,000 28,000 Total deferred tax assets 4,973,000 4,455,000 Valuation allowance (4,973,000 ) (4,455,000 ) Net deferred tax assets $ - $ - At December 31, 2021 the Company had net operating loss carry forwards of approximately $18,200,000 for federal and state purposes, $10,000,000 of which expire between 2022 through 2039. The remaining balance of $8,200,000 will never expire but utilization is limited to 80% of taxable income in any future year. The reconciliation of the federal income tax rate and the Company’s tax provision (benefit) at December 31, 2021 is as follows: 2021 2020 Net loss $ (2,675,852 ) $ (4,006,713 ) Less non-controlling interest net loss 228,223 70,327 Net loss attributable to CBDS $ (2,447,629 ) $ (3,936,386 ) Provision (benefit) computed using the statutory rate: $ (514,000 ) $ (827,000 ) Permanent differences - 92,000 Change in estimate (4,000 ) - Change in valuation allowance 518,000 735,000 Total income tax provision (benefit) $ - $ - The Company has analyzed its filing positions in all jurisdictions where it is required to file income tax returns and found no positions that would require a liability for uncertain income tax benefits to be recognized. The Company is subject to possible tax examinations for the fiscal years 2018 through 2021. Prior year tax attributes could be adjusted by taxing authorities. If applicable, the Company will deduct interest and penalties as interest expense on the financial statements.

COVID- 19

COVID- 19	12 Months Ended
	Dec. 31, 2021
COVID- 19
10. COVID- 19	10. COVID-19: The outbreak of COVID-19, the coronavirus, has grown both in the United States and globally, and related government and private sector responsive actions have adversely affected the Company’s business operations. The World Health Organization has declared Covid-19 to be a global pandemic, resulting in an economic downturn and changes in global economic policy that will reduce demand for the Company’s products and may have an adverse impact on the Company’s business, operating results and financial condition.

Organization and Summary of S_2

Organization and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Organization and Summary of Significant Accounting Policies (Policies)
Nature of Business	Cannabis Sativa, Inc. (the “Company,” “us”, “we” or “our”) was incorporated as Ultra Sun Corp. under the laws of Nevada in November 2004. On November 13, 2013, we changed our name to Cannabis Sativa, Inc. We operate through several subsidiaries including: · PrestoCorp, Inc. (“PrestoCorp”) · iBudtender, Inc. (“iBud”) – through April 2021 · Wild Earth Naturals, Inc. (“Wild Earth”) · Kubby Patent and Licenses Limited Liability Company (“KPAL”) · Hi Brands, International, Inc. (“Hi Brands”) · GK Manufacturing and Packaging, Inc. (“GKMP”)- through April 2021 · Eden Holdings LLC (“Eden”). PrestoCorp is a 51% owned subsidiary and until April 22, 2021, GKMP and iBud were 51% and 50.1% owned subsidiaries. Wild Earth, KPAL, Hi Brands, and Eden are wholly owned subsidiaries. At December 31, 2021, PrestoCorp is the sole operating subsidiary. Until sale of the Company’s interest in April 2021, GKMP and iBud tender were operating subsidiaries although iBud was not generating any revenue. Our primary operations for the years ended December 31, 2021 and 2020 were through PrestoCorp, which provides telemedicine online referral services for customers desiring medical marijuana cards in states where medical marijuana has been legalized. The Company is actively seeking new business opportunities for acquisition and is continually reviewing opportunities for product and brand development through our Wild Earth, Hi Brands, and KPAL subsidiaries.
Principles of Consolidation	The consolidated financial statements include the accounts of Cannabis Sativa, Inc. (the “Company” or “CBDS”), and its wholly-owned subsidiaries and PrestoCorp, a 51% owned subsidiary. On April 22, 2021, we sold our interests in two companies in which the Company had majority control, iBud and GKMP. These consolidated financial statements include operations of iBud and GKMP through April 22, 2021. All significant inter-company balances have been eliminated in consolidation.
Non-controlling Interests	Non-controlling interests are portions of entities included in the condensed consolidated financial statements that are not attributable to the Company. Non-controlling interest are identified separately from the Company’s stockholders’ equity and its net income (loss). Non-controlling interest equity balances include the non-controlling entity’s initial contribution at the date of the original acquisition, ongoing contributions, distributions, and percentage share of earnings since inception. The non-controlling interests are calculated based on percentages of ownership.
Going Concern	The Company has an accumulated deficit of $79,475,968 and negative working capital of $1,115,082 at December 31, 2021, which, among other factors, raises substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to generate profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they are due.
Use of Estimates	The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”), requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant estimates and assumptions by management affect the carrying value of long-lived assets (including goodwill and intangible assets), the provision for income taxes and related deferred tax accounts, certain accrued liabilities, contingencies, and the value attributed to stock-based awards.
Inventories	As of December 31, 2021 and 2020, the Company had $-0- and $56,485, respectively, in inventory relating to GKMP which consisted of the raw materials and packaging used to manufacture cannabidiol (“CBD”) infused products for our customers.
Property and Equipment	Property and equipment are recorded at cost. Depreciation is provided for on the straight-line method over the estimated useful lives of the assets. The average lives range from five (5) to ten (10) years. Leasehold improvements are amortized on the straight-line method over the lesser of the lease term or the useful life. When assets are retired or sold, the costs and related accumulated depreciation are eliminated from the accounts and any resulting gain or loss is reflected in operations. Maintenance and repairs that neither materially add to the value of the property nor appreciably prolong its life are charged to expense as incurred. Betterments or renewals are capitalized when incurred.
Fair Value of Financial Instruments	The carrying amounts of cash and cash equivalents and balances due to related parties approximate fair value given their short-term nature. The carrying value of investments in equity securities equal fair value.
Cash	Cash is held at major financial institutions and insured by the Federal Deposit Insurance Corporation (FDIC) up to federal insurance limits. The Company considers all highly liquid investments purchased with an original maturity of three months or less when acquired to be cash equivalents.
Net Loss per Share	Basic net loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding for the period and contains no dilutive securities. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of the Company. Potentially dilutive shares are excluded from the calculation of diluted net loss per share because the effect is anti-dilutive. For the years ended December 31, 2021 and 2020, the Company had 175,000 and 175,000 outstanding warrants, respectively, and 777,654 and 1,090,128 shares of convertible preferred stock, respectively, that would be dilutive to future periods net income if converted.
Investments	Equity securities of investments in which the Company owns less than 20% and/or has no significant influence are generally measured at fair value with changes in fair value recognized in earnings. Upon sale of an equity security, the realized gain or loss is recognized in earnings. Investments in companies in which the Company owns more than 20% and has the ability to exercise significant influence, but do not control, are accounted for under the equity method of accounting. In determining whether significant influence exists, the Company will consider its participation in policy-making decisions and representation on governing bodies. Under the equity method of accounting, the Company’s share of the net earnings or losses of the investee are included in earnings. The Company may elect to account for certain equity method investments at fair value whereby the carrying value of the investment is adjusted to fair value at the end of each period and the related change in fair value is recognized in earning. For these investments, the Company’s share of the net earnings or losses of the investee are not included in earnings. Companies in which the Company holds investments amounting to more than 50% of the voting interests, but less than 100%, and in which the Company has significant influence, are consolidated and other investor interests are presented as non-controlling.
Revenue Recognition	In the years ending December 31, 2021 and 2020, the Company operated two divisions, the telehealth business operated through PrestoCorp and the contract manufacturing business operated through GKMP. The contract manufacturing business was sold on April 22, 2021, and the Company now operates only the telehealth division. The telehealth division generates revenue based on a per telehealth visit for clients looking to obtain a permit to use marijuana for medical purposes in states that have legalized medical marijuana. Revenues are recognized when the Company satisfies its performance obligation to provide telehealth services upon a referral to a contracted physician. The obligation to perform the referral and the referral are automated and occur at the same time an online client subscribes for the visit and gains access to our network of health care professionals. Recognition of revenue is not dependent on the issuance of a marijuana card since issuance of the card is dependent on health and other factors beyond our control. This initial service is a one-time referral to a physician. Clients may return for other telehealth consultations, typically regarding product recommendations, and such additional physician referrals are provided at an additional cost. The billing and payment processes for each physician referral are automated through our online platform. Revenue is recognized in an amount that reflects the consideration that is received in exchange for each physician referral provided to the client. The contract manufacturing division recognized revenue from manufacturing operations when the products are shipped to the customer. In some instances, customers provided inventory for the manufacturing process and GKMP provided labor, supplies and manufacturing operations to mix and package the products. Revenues were recognized when the manufacturing and packaging process were completed, and the goods were shipped to the customer. In other instances, the Company acquired inventory and manufactured products for customers and/or to be held in inventory for later sale to customers through the GKMP on-site dispensary, through the GKMP online store, or to independent distributors. In these instances, revenue was recognized when the product was shipped to the customer or distributor. Shipment terms were FOB origination. The Company sold its interest in GKMP during 2021 and no longer recognizes revenue from the contract manufacturing division. Provision for sales incentives, discounts and returns and allowances, if applicable, are accounted for as reductions of revenue in the period the related sales are recorded. The Company had no warranty costs associated with the sales of its products.
Intangible Assets and Goodwill	Intangible asset amounts represent the acquisition date fair values of identifiable intangible assets acquired. The fair values of the intangible assets were determined by using the income approach, discounting projected future cash flows based on management’s expectations of the current and future operating environment. The rates used to discount projected future cash flows reflected a weighted average cost of capital based on our industry, capital structure and risk premiums including those reflected in the current market capitalization. Definite-lived intangible assets are amortized over their useful lives, which have historically ranged from 5 to 10 years. The carrying amounts of our definite-lived intangible assets are evaluated for recoverability whenever events or changes in circumstances indicate that the entity may be unable to recover the asset’s carrying amount. We do not have any indefinite-lived intangible assets recorded from acquisitions. Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill is not amortized but is tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset may be impaired. The fair value of the reporting unit is evaluated on qualitative factors to determine if the reported value may be impaired. If the qualitative factors indicate a likelihood of impairment, we then evaluate carrying value of the reporting unit based on quantitative factors using the income approach. An impairment charge is recognized for the excess of the carrying value of goodwill for the reporting unit over its implied fair value.
Advertising Expense	Advertising costs are expensed as incurred and are broken out separately in the accompanying consolidated statements of operations.
Stock-Based Compensation	Stock-based payments to employees and non-employees are recognized at their fair values. Compensation expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). Transactions in which goods or services are received for the issuance of shares of the Company’s preferred or common stock are accounted for based on the fair value of the common stock issued. The Company currently recognizes compensation costs immediately as our awards are 100% vested at the time of issuance. Forfeitures are recognized upon occurrence.
Income Taxes	The Company utilizes the liability method of accounting for income taxes which requires that deferred tax assets and liabilities be recorded to reflect the future tax consequences of temporary differences between the book and tax basis of various assets and liabilities. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Additionally, deferred tax assets are evaluated, and a valuation allowance is established if it is more likely than not that all or a portion of the deferred tax asset will not be realized. There can be no assurance that the Company’s future operations will produce sufficient earnings so that the deferred tax asset can be fully utilized. The Company currently maintains a full valuation allowance against net deferred tax assets. Uncertain tax positions are evaluated in a two-step process, whereby (i) it is determined whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (ii) for those tax positions that meet the more-likely-than-not recognition threshold, the largest amount of tax benefit that is greater than 50% likely of being realized upon ultimate settlement with the related tax authority would be recognized.
Leases	The Company determines if an arrangement is a lease, or contains a lease, at the inception of an arrangement. If the Company determines that the arrangement is a lease, or contains a lease, at lease inception, it then determines whether the lease is an operating lease or finance lease. Operating and finance leases result in recording a right-to-use (“RTU”) asset and lease liability on the consolidated balance sheets. RTU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease RTU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. For purposes of calculating operating lease RTU assets and operating lease liabilities, the Company uses the non-cancellable lease term plus options to extend that it is reasonably certain to exercise. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. The Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company has elected not to recognize RTU assets and lease liabilities that arise from short-term (12 months or less) leases for any class of underlying asset. The Company has elected not to separate lease and non-lease components for any class of underlying asset.
Fair Value Measurements	When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. We measure our investment in equity securities at fair value on a recurring basis. The Company’s equity securities are valued using inputs observable in active markets and are therefore classified as Level 1 within the fair value hierarchy.
Contingencies	In determining accruals and disclosures with respect to loss contingencies, the Company evaluates such accruals and contingencies for each reporting period. Estimated losses from loss contingencies are accrued by a charge to income when information available prior to issuance of the financial statements indicates that it is probable that a liability could be incurred, and the amount of the loss can be reasonably estimated. Legal expenses associated with the contingency are expensed as incurred. If a loss contingency is not probable or reasonably estimable, disclosure of the loss contingency is made in the financial statements when it is at least reasonably possible that a material loss could be incurred.
Recent Accounting Pronouncement	Accounting Standards Updates Adopted In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The update contains a number of provisions intended to simplify the accounting for income taxes. Adoption of this update on January 1, 2021 had no impact on the Company’s consolidated financial statements. Accounting Standards Updates to Become Effective in Future Periods In August 2020, the FASB issued ASU No. 2019-12 Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The update is to address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity. The update is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years and with early adoption permitted. Management is evaluating the impact of this update on the Company’s consolidated financial statements. Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption.

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2021
Property and Equipment (Tables)
Schedule of Property and Equipment	2021 2020 Furniture and Equipment $ 15,052 $ 225,629 Leasehold Improvements 2,500 17,315 Total Property and Equipment 17,552 242,944 Less: Accumulated Depreciation (15,578 ) (43,824 ) Net Property and Equipment $ 1,974 $ 199,120

Intangibles and Goodwill (Table

Intangibles and Goodwill (Tables)	12 Months Ended
	Dec. 31, 2021
Property and Equipment (Tables)
Schedule of Intangible Assets	2021 2020 CBDS.com website (Cannabis Sativa) $ 13,999 $ 13,999 Intellectual Property Rights (PrestoCorp) 240,000 240,000 Patents and Trademarks (KPAL) 1,281,411 1,281,411 Total Intangibles 1,535,410 1,535,410 Less: Accumulated Amortization (1,214,604 ) (1,045,464 ) Net Intangible Assets $ 320,806 $ 489,946
Schedule of amortization	Amortization of intangibles through 2026 is: 2022 $ 161,865 2023 151,686 2024 3,051 2025 932 2026 932

Sale of Majority Owned Subsid_2

Sale of Majority Owned Subsidiaries and Discontinued Operations (Tables)	12 Months Ended
	Dec. 31, 2021
Sale of Majority Owned Subsidiaries and Discontinued Operations
Summary of the discontinued operations of GKMP and iBud	Period Year Ended Ended DISCONTINUED OPERATIONS OF GKMP January 1 to April 22, 2021 December 31, 2020 REVENUE $ 75,866 $ 94,552 Cost of revenues 91,316 152,837 Gross profit (15,450 ) (58,285 ) OPERATING EXPENSES Depreciation and amortization 5,526 8,898 Wages and salaries 106,224 213,765 Advertising 1,693 36,056 General and administrative 104,177 433,592 Total operating expenses 217,620 692,311 NET LOSS FROM OPERATIONS (233,070 ) (750,596 ) DISCONTINUED OPERATIONS OF IBUD REVENUE $ - $ - OPERATING EXPENSES Depreciation and amortization 1,135 1,004 Total operating expenses 1,135 1,004 NET LOSS FROM OPERATIONS (1,135 ) (1,004 ) Aggregate net loss from discontinued operations (234,205 ) (751,600 ) Gain on sale of discontinued operations 164,736 - NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS (69,469 ) (751,600 )
Summary of value of the consideration received	Consideration received: Common stock of CBDG, fair value $ 300,000 Preferred stock of CBDG, fair value 300,000 Total consideration 600,000 Non-controlling interests (331,884 ) Net assets of subsidiaries on date of disposition: GKMP 112,350 iBud (8,970 ) Net assets 103,380 Gain on sale of subsidiaries $ 164,736

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Dec. 31, 2021
Related Party Transactions (Tables)
Schedule of related party advance and note payable	The following tables reflect the related party advance and note payable balances. Notes payable to related parties Accrued interest -related parties December 31, 2021 David Tobias, CEO & Director $ 986,538 $ 169,057 New Compendium, greater than 10% Shareholder 152,500 27,688 Cathy Carroll, Director 75,000 7,068 Other Affiliates 4,000 800 Totals $ 1,218,038 $ 204,613 Advances from related parties Notes payable to related parties Accrued interest -related parties December 31, 2020 David Tobias, CEO & Director $ — $ 944,378 $ 120,293 New Compendium, Affiliate — 152,500 20,063 Keith Hyatt, Affiliate (GKMP) 13,100 — — Jason Washington, Affiliate (GKMP) 5,700 — — Chris Cope, Affiliate (iBudtender) — 10,142 — Cathy Carroll, Director — 50,000 3,068 Other Affiliates — 4,000 600 Totals $ 18,800 $ 1,161,020 $ 144,024

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2021
Related Party Transactions (Tables)
Related and non-related parties	During the years ended December 31, 2021 and 2020, shares of common stock and preferred stock were issued to related and non-related parties for the purposes indicated, as follows: Share Issuances Services Common Preferred Value Related Party issuances David Tobias, Officer, Director - 310,171 $ 150,000 Brad Herr, Officer, Director 516,949 - 250,000 Robert Tankson, Director 61,236 - 29,961 Cathy Carroll, Director 203,027 - 112,500 Trevor Reed, Director 51,696 - 25,000 Total related party issuances 832,908 310,171 $ 567,461 Non-related party issuances 1,883,224 - $ 941,746 Total shares for services 2,716,132 310,171 $ 1,509,207 Issuance for cash 10,466 5,000 Preferred stock converted to common 622,645 (622,645 ) - Shares cancelled (55,556 ) - $ (20,000 ) Aggregate totals 3,293,687 (312,474 ) $ 1,494,207 During the year ended December 31, 2021, the Company cancelled shares that had been returned after it was determined the shares have been erroneously issued to a vendor in 2020. Share Issuances Shares issued for stock payable Common Preferred Value Related party issuance 521,411 223,214 $ 431,201 Non-related party issuance 441,827 - 209,484 Total shares for stock payable 963,238 223,214 $ 640,685 Conversion of preferred stock 503,681 (503,681 ) $ - Services Related party issuances David Tobias, Officer, Director - 348,746 $ 175,964 Brad Herr, Officer, Director 498,878 - 250,201 Robert Tankson, Director 127,570 - 62,661 Cathy Carroll, Director 348,746 - 175,964 Trevor Reed, Director 58,125 - 29,328 Keith Hyatt, President GKMP 278,237 - 140,237 Kyle Powers, CEO PrestoCorp 92,593 - 44,444 Total related party issuances 1,404,149 348,746 878,799 Non-related Party issuances 2,207,911 - 1,177,794 Total shares for services 3,612,060 348,746 $ 2,056,593 Issuance for Cash 50,000 - $ 25,000 Issuance for acquisitions 100,000 - $ 109,000 Aggregate totals 5,228,979 68,279 $ 2,831,278
Schedule of warrants expiration	During the year ended December 31, 2020, 50,000 warrants were issued by the Company and 49,900 warrants expired. No warrants were issued or exercised in 2021 and no warrants were exercised during either year. At December 31, 2021, warrants expire as follows: Shares Exercise Price Expiration Date 125,000 $ 0.80 November 2022 50,000 $ 2.00 July and August 2023 175,000

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Income Taxes
Schedule of components of deferred tax assets	The components of the Company’s net deferred tax assets at December 31, 2021 and 2020 are as follows: 2021 2020 Deferred tax asset: Net operating loss carryforwards $ 3,812,000 $ 3,424,000 Intangibles and goodwill 1,034,000 998,000 Investments 82,000 5,000 Other 45,000 28,000 Total deferred tax assets 4,973,000 4,455,000 Valuation allowance (4,973,000 ) (4,455,000 ) Net deferred tax assets $ - $ -
Schedule of Effective Income Tax Rate Reconciliation	The reconciliation of the federal income tax rate and the Company’s tax provision (benefit) at December 31, 2021 is as follows: 2021 2020 Net loss $ (2,675,852 ) $ (4,006,713 ) Less non-controlling interest net loss 228,223 70,327 Net loss attributable to CBDS $ (2,447,629 ) $ (3,936,386 ) Provision (benefit) computed using the statutory rate: $ (514,000 ) $ (827,000 ) Permanent differences - 92,000 Change in estimate (4,000 ) - Change in valuation allowance 518,000 735,000 Total income tax provision (benefit) $ - $ -

Organization and Summary of S_3

Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Accumulated deficit	$ 79,475,968	$ 77,028,339
Working capital	$ (1,115,082)
Uncertain tax positions description	Uncertain tax positions are evaluated in a two-step process, whereby (i) it is determined whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (ii) for those tax positions that meet the more-likely-than-not recognition threshold, the largest amount of tax benefit that is greater than 50% likely of being realized upon ultimate settlement with the related tax authority would be recognized.
Inventories	$ 0	$ 56,485
Minimum [Member]
Finite-Lived Intangible Asset, Useful Life	5 years
Property and Equipment, Useful Life	5 years
Maximum [Member]
Finite-Lived Intangible Asset, Useful Life	10 years
Property and Equipment, Useful Life	10 years
Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	175,000	175,000
Convertible Series A Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	777,654	1,090,128
GK Manufacturing Inc
Equity Method Investment, Ownership Percentage	51.00%
IBud [Member]
Equity Method Investment, Ownership Percentage	50.10%
David Tobias [Member]
Equity Method Investment, Ownership Percentage	51.00%

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment, Gross	$ 17,552	$ 242,944
Less: accumulated depreciation	(15,578)	(43,824)
Property and Equipment, Net	1,974	199,120
Furniture and Fixtures [Member]
Property, Plant and Equipment, Gross	15,052	225,629
Leasehold Improvements [Member]
Property, Plant and Equipment, Gross	$ 2,500	$ 17,315

Property and Equipment (Detai_2

Property and Equipment (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Property and Equipment
Depreciation expense	$ 18,972	$ 30,352

Intangibles and Goodwill (Detai

Intangibles and Goodwill (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Less: Accumulated Amortization	$ (1,214,604)	$ (1,045,464)
Finite-Lived Intangible Assets, Net	320,806	489,946
Finite-Lived Intangible Assets, Gross	1,535,410	1,535,410
Cannabis Sativa [Member] | Internet Domain Names [Member]
Finite-Lived Intangible Assets, Gross	13,999	13,999
Prestocorp [Member] | Intellectual Property [Member]
Finite-Lived Intangible Assets, Gross	240,000	240,000
K P A L [Member] | Patents And Trademarks [Member]
Finite-Lived Intangible Assets, Gross	$ 1,281,411	$ 1,281,411

Intangibles and Goodwill (Det_2

Intangibles and Goodwill (Details 1)	Dec. 31, 2021USD ($)
Intangibles and Goodwill
2022	$ 161,865
2023	151,686
2024	3,051
2025	932
2026	$ 932

Intangibles and Goodwill (Det_3

Intangibles and Goodwill (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Amortization of Intangible Assets	$ 169,140	$ 205,272
Goodwill	1,837,202	1,837,202
August 1, 2017 [Member] | Prestocorp [Member]
Impairment of goodwill	3,010,202
Cumulative impairment of goodwill	$ 1,173,000	$ 1,173,000
Minimum [Member]
Finite-Lived Intangible Asset, Useful Life	5 years
Maximum [Member]
Finite-Lived Intangible Asset, Useful Life	10 years

Sale of Majority Owned Subsid_3

Sale of Majority Owned Subsidiaries (Details) - USD ($)	1 Months Ended	12 Months Ended
	Apr. 22, 2021	Dec. 31, 2021	Dec. 31, 2020
Total consideration	$ 600,000	$ 600,000
Non-controlling interests		(331,884)
Net assets		103,380
Gain on sale of subsidiaries		$ 164,736	$ 0
Total consideration		21,321	0
Preferred Stock [Member]
Total consideration		$ 300,000
Total consideration	1,500,000
Common Stock [Member]
Total consideration	$ 300,000
Total consideration	1,500,000	300,000
GK Manufacturing Inc
Net assets		$ 112,350
IBud [Member]
Net assets		$ (8,970)

Sale of Majority Owned Subsid_4

Sale of Majority Owned Subsidiaries (Details 1) - USD ($)	4 Months Ended	12 Months Ended
	Apr. 22, 2021	Dec. 31, 2021	Dec. 31, 2020
REVENUE		$ 1,841,558	$ 1,940,731
Cost of revenues		699,378	740,645
Gross profit		1,142,180	1,200,086
Depreciation and amortization		171,163	207,866
Wages and salaries		711,872	596,262
Advertising		344,904	467,918
General and administrative		1,078,204	971,598
Total operating expenses		2,887,803	2,993,674
NET LOSS FROM OPERATIONS		(2,349,937)	(1,706,944)
NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS		$ (69,469)	(751,600)
IBud [Member]
REVENUE	$ 0		0
Depreciation and amortization	1,135		1,004
Total operating expenses	1,135		1,004
NET LOSS FROM OPERATIONS	(1,135)		(1,004)
Aggregate net loss from discontinued operations	(234,205)		(751,600)
Gain on sale of discontinued operations	164,736		0
NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS	(69,469)		(751,600)
G K M P [Member]
REVENUE	75,866		94,552
Cost of revenues	91,316		152,837
Gross profit	(15,450)		(58,285)
Depreciation and amortization	5,526		8,898
Wages and salaries	106,224		213,765
Advertising	1,693		36,056
General and administrative	104,177		433,592
Total operating expenses	217,620		692,311
NET LOSS FROM OPERATIONS	$ (233,070)		$ (750,596)

Sale of Majority Owned Subsid_5

Sale of Majority Owned Subsidiaries (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Apr. 22, 2021	Dec. 31, 2021	Dec. 31, 2020
Gain on sale of subsidiaries		$ 164,736	$ 0
Sale of stock value	$ 600,000	$ 600,000
Sale of transaction		21,321	0
GK Manufacturing Inc
Equity Method Investment, Ownership Percentage		51.00%
IBud [Member]
Equity Method Investment, Ownership Percentage		50.10%
Preferred Stock [Member]
Sale of stock value		$ 300,000
Sale of transaction	1,500,000
Common Stock [Member]
Sale of stock value	$ 300,000
Sale of transaction	1,500,000	300,000
Share Price	$ 0.20

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Notes Payable to Related Parties	$ 1,218,038	$ 1,161,020
Accrued interest - related parties	204,613	144,024
Related Party Advances		18,800
New Compendium Affiliate [Member]
Notes Payable to Related Parties	152,500	152,500
Accrued interest - related parties	27,688	20,063
Related Party Advances		0
David Tobias, CEO & Director [Member]
Notes Payable to Related Parties	986,538	944,378
Accrued interest - related parties	169,057	120,293
Related Party Advances		0
Cathy Carroll, Director
Notes Payable to Related Parties	75,000	50,000
Accrued interest - related parties	7,068	3,068
Related Party Advances		0
Other Affiliates [Member]
Notes Payable to Related Parties	4,000	4,000
Accrued interest - related parties	$ 800	600
Related Party Advances		0
Keith Hyatt Affiliate [Member]
Notes Payable to Related Parties		0
Accrued interest - related parties		0
Related Party Advances		13,100
Jason Washington Affiliate [Member]
Notes Payable to Related Parties		0
Accrued interest - related parties		0
Related Party Advances		5,700
Chris Cope Affilitate [Member]
Notes Payable to Related Parties		10,142
Accrued interest - related parties		0
Related Party Advances		0
David Tobias [Member]
Accrued interest - related parties		$ 120,293

Related Party Transactions (D_2

Related Party Transactions (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Debt Instrument, Interest Rate, Stated Percentage		5.00%
Interest Expense	$ 66,872	$ 60,356
Principal Amount		142,500
Advances from and payables to related parties	48,083
Ibudtender Inc [Member]
Note Payable	10,142
David Tobias [Member]
Principal Amount	$ 42,160
Due Date	Dec. 31, 2021
Interest rate	5.00%
G K M P [Member]
Principal Amount	$ 67,058
Cathy Carroll, Director
Principal Amount	$ 25,000
Due Date	Dec. 31, 2021
Interest rate	5.00%
Consultant [Member]
Other General and Administrative Expense	$ 111,100	$ 162,300
Minimum [Member]
Debt Instrument, Interest Rate, Stated Percentage	5.00%
Maximum [Member]
Debt Instrument, Interest Rate, Stated Percentage	8.00%

Investments (Details Narrative)

Investments (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2021	Dec. 31, 2020
Stock Issued During Period, Shares, Purchase of Assets		8,238,769	10,000,000
Recognized unrealized gains (losses) on investment	$ 147,000	$ (134,235)
Share price		$ 0.20
Fair value of investment		$ 82,000	$ 5,000
Sale of transaction		21,321	0
C B D G [Member]
Stock Issued During Period, Shares, Purchase of Assets		1,500,000	1,500,000
Proceeds from sales of equity		$ 600,000
Percentage of voting share held by director		15.00%
Fair value of investment		$ 183,000
Unrealized gain on investment		(417,000)
R E F G [Member]
Proceeds from sales of equity		44,017
Fair value of investment		25,540	$ 195,000
Realized gain		$ 8,793
Sale of transaction		1,761,231

Stockholders Equity (Details)

Stockholders Equity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Issuance for cash, value	$ 5,000	$ 25,000
Issuance for acquisitions, value		109,000
Total shares for stock payable, value		640,685
Total shares for stock payable, Related Party		431,201
Total shares for stock payable, Non Related Party		209,484
Shares cancelled, value	(20,000)
Aggregate totals, value	1,494,207	2,831,278
Stock issued for services, value	$ 1,509,207	$ 2,056,593
Conversion of stock, share issued	622,645	503,681
Preferred Stock
Total shares for stock payable share		223,214
Total shares for stock payable Related Party share		223,214
Aggregate totals, shares	312,474	(68,279)
Conversion of stock, shares converted	(622,645)	503,681
Common Stock
Issuance for cash, share	10,466	50,000
Total shares for stock payable share		963,238
Issuance for acquisitions, share		100,000
Total shares for stock payable Related Party share		521,411
Total shares for stock payable Non Related Party share		441,827
Conversion of stock, share issued	622,645	503,681
Shares cancelled, share	(55,556)
Aggregate totals, shares	3,293,687	5,228,979
Total shares for services [Member] | Common Stock [Member]
Stock issued for services, share	2,716,132	3,612,060
Total shares for services [Member] | Preferred Stock [Member]
Stock issued for services, share	310,171	348,746
Cathy Carroll, Director
Stock issued for services, value	$ 112,500	$ 175,964
Cathy Carroll, Director | Common Stock [Member]
Stock issued for services, share	203,027	348,746
David Tobias, Officer, Director
Stock issued for services, value	$ 150,000	$ 175,964
David Tobias, Officer, Director | Preferred Stock [Member]
Stock issued for services, share	310,171	348,746
Robert Tankson, Director
Stock issued for services, value	$ 29,961	$ 62,661
Robert Tankson, Director | Common Stock [Member]
Stock issued for services, share	61,236	127,570
Brad Herr, Officer, Director
Stock issued for services, value	$ 250,000	$ 250,201
Brad Herr, Officer, Director | Common Stock [Member]
Stock issued for services, share	516,949	498,878
Conversion
Conversion of stock, shares converted Value	$ 0	$ 0
Keith Hyatt, President
Stock issued for services, value		$ 140,237
Keith Hyatt, President | Common Stock [Member]
Stock issued for services, share		278,237
Trevor Reed, Director
Stock issued for services, value	$ 25,000	$ 29,328
Trevor Reed, Director | Common Stock [Member]
Stock issued for services, share	51,696	58,125
Kyle Powers, CEO
Stock issued for services, value		$ 44,444
Kyle Powers, CEO | Common Stock [Member]
Stock issued for services, share		92,593
Total Related Party Issuances
Stock issued for services, value	$ 567,461	$ 878,799
Total Related Party Issuances | Common Stock [Member]
Stock issued for services, share	832,908	1,404,149
Total Related Party Issuances | Preferred Stock [Member]
Stock issued for services, share	310,171	348,746
Non-Related Party Issuances
Stock issued for services, value	$ 941,746	$ 1,177,794
Non-Related Party Issuances | Common Stock [Member]
Stock issued for services, share	1,883,224	2,207,911

Stockholders Equity (Details 1)

Stockholders Equity (Details 1)	12 Months Ended
	Dec. 31, 2021$ / sharesshares
Number of warrants	175,000
Warrant 1
Number of warrants	125,000
Warrant, Exercise price | $ / shares	$ 0.80
Warrants Expiration Date	November 2022
Warrant 2
Number of warrants	50,000
Warrant, Exercise price | $ / shares	$ 2
Warrants Expiration Date	July and August 2023

Stockholders Equity (Details Na

Stockholders Equity (Details Narrative) - USD ($)	1 Months Ended			12 Months Ended
	Jan. 27, 2021	Sep. 25, 2020	Jul. 28, 2017	Dec. 31, 2021	Dec. 31, 2020
Conversion of stock, shares issued				622,645	503,681
Interest acquired in GKMP					51.00%
Consideration for the acquisition shares					100,000
Acquisition shares of common stock valued					$ 109,000
Warrants
Number of warrants issued					50,000
Warrants expired					49,900
2017 Stock Plan
Common Stock issued to compensate employees and consultants			3,000,000
2021 Stock Plan
Shares available for future issuance				1,350,667
2020 Stock Plan
Common Stock issued to compensate employees and consultants	2,000,000	1,000,000
Shares available for future issuance				1,000,000
Increased number of shares available for future issuance				2,000,000

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Shares in Escrow	the Company has -0- and 419,475, respectively, shares of common stock in escrow as part of the acquisition of PrestoCorp. These shares were issuable in certain circumstances to the principals of PrestoCorp based on performance of the PrestoCorp business. The escrow account originally contained 629,213 shares of common stock but 209,738 shares were cancelled in 2018 when the performance requirements related to those shares were not met. Another 209,738 shares were released to the principals in January 2021 upon satisfaction of performance requirements for which compensation expense of $111,161 was recognized during the year ended December 31, 2021
New York office Facilities | Prestocorp [Member]
Debt Instrument, Periodic Payment	$ 2,444
David Tobias [Member]
Operating Leases, Rent Expense	36,922	$ 38,458
G K M P [Member]
Operating Leases, Rent Expense	7,555	22,527
Rent expence	$ 77,119	$ 139,398

Income Taxes (Details)

Income Taxes (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Deferred tax assets:
Net operating loss carryforwards	$ 3,812,000	$ 3,424,000
Goodwill and intangibles	1,034,000	998,000
Investments	82,000	5,000
Other	45,000	28,000
Total deferred tax assets	4,973,000	4,455,000
Valuation allowance	(4,973,000)	(4,455,000)
Net deferred tax asset	$ 0	$ 0

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Taxes
Net Loss	$ (2,675,852)	$ (4,006,713)
Less non-controlling interests net loss	228,223	70,327
Net loss attributable to CBDS	(2,447,629)	(3,936,386)
Provision (benefit) computed using the statutory rate	(514,000)	(827,000)
Permanent differences	0	92,000
Change in estimate	(4,000)	0
Change in valuation allowance	518,000	735,000
Total income tax provision (benefit)	$ 0	$ 0

Income Taxes (Details Narrative

Income Taxes (Details Narrative)	12 Months Ended
	Dec. 31, 2021USD ($)
Income Taxes
Operating loss carry forwards	$ 10,000,000
Federal and state Operating loss carry forwards	$ 18,200,000
Federal and state Operating loss carry forwards expiartion date	between 2022 through 2039
Utilization of Remaining balance of Taxable income, Description	The remaining balance of $8,200,000 will never expire but utilization is limited to 80% of taxable income in any future year.